Table 1 Clinical characteristics of training and testing cohorts
Training Cohort | Testing Cohort | |||
|---|---|---|---|---|
Control (n = 55) | Aneurysm (n = 39) | Control (n = 24) | Aneurysm (n = 16) | |
Age (Mean ± SE) | 62 ± 2.0 | 61 ± 1.7 | 59 ± 2.9 | 57 ± 3.3 |
Age [Median (Q1/Q3)] | 66 (54/72) | 60 (54/68) | 59 (54/68) | 58.5 (49.25/63.25) |
Sex (% of patients) | ||||
Female | 56.36% | 69.23% | 50% | 75% |
Smoker (% of patients) | ||||
Yes | 10.91% | 26.64% | 20.83% | 43.75% |
Comorbidities (% of patients) | ||||
Hypertension | 61.82% | 53.85% | 54.17% | 50% |
Heart disease | 30.91% | 23.08% | 25% | 18.75% |
High cholesterol | 52.73% | 48.72% | 62.50% | 50% |
Stroke history | 12.73% | 10.26% | 25% | 0% |
Diabetes | 29.09% | 17.95% | 8.33% | 31.25% |
Arthritis | 16.36% | 30.77% | 16.67% | 18.75% |